Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa.
AffiliationInfectious Disease Epidemiology Unit, School of Public Health and Family Medicine, University of Cape Town, Anzio Road, Observatory 7925, South Africa.
MetadataShow full item record
JournalAIDS (London, England)
AbstractBACKGROUND: A community-based antiretroviral therapy (ART) programme was established in 2001 in a South African township to explore the operational issues involved in providing ART in the public sector in resource-limited settings and demonstrate the feasibility of such a service. METHODS: Data was analysed on a cohort of patients with symptomatic HIV disease and a CD4 lymphocyte count < 200 x 10 cells/l. The programme used standardized protocols (using generic medicines whenever possible), a team-approach to clinical care and a patient-centred approach to promote adherence. RESULTS: Two-hundred and eighty-seven adults naive to prior ART were followed for a median duration of 13.9 months. The median CD4 lymphocyte count was 43 x 10 cells/l at initiation of treatment, and the mean log10 HIV RNA was 5.18 copies/ml. The HIV RNA level was undetectable (< 400 copies/ml) in 88.1, 89.2, 84.2, 75.0 and 69.7% of patients at 3, 6, 12, 18 and 24 months respectively. The cumulative probability of remaining alive was 86.3% at 24 months on treatment for all patients, 91.4% for those with a baseline CD4 lymphocyte count > or =50 x 10 cells/l, and 81.8% for those with a baseline CD4 lymphocyte count < 50 x 10 cells/l. The cumulative probability of changing a single antiretroviral drug by 24 months was 15.1% due to adverse events or contraindications, and 8.4% due to adverse events alone. CONCLUSIONS: ART can be provided in resource-limited settings with good patient retention and clinical outcomes. With responsible implementation, ART is a key component of a comprehensive response to the epidemic in those communities most affected by HIV.
- Public-sector ART in the Free State Province, South Africa: community support as an important determinant of outcome.
- Authors: Wouters E, Van Damme W, Van Loon F, van Rensburg D, Meulemans H
- Issue date: 2009 Oct
- [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
- Authors: Panel de expertos de Gesida y Plan Nacional sobre el Sida.
- Issue date: 2009 Apr
- Implementation of an antiretroviral access program for HIV-1-infected individuals in resource-limited settings: clinical results from 4 African countries.
- Authors: Sow PS, Otieno LF, Bissagnene E, Kityo C, Bennink R, Clevenbergh P, Wit FW, Waalberg E, Rinke de Wit TF, Lange JM, Cohort Program to Evaluate Access to Antiretroviral Therapy and Education Project Team.
- Issue date: 2007 Mar 1
- Efficacy of highly active antiretroviral therapy in HIV-1 infected children in Kenya.
- Authors: Song R, Jelagat J, Dzombo D, Mwalimu M, Mandaliya K, Shikely K, Essajee S
- Issue date: 2007 Oct
- Second-line antiretroviral therapy in resource-limited settings: the experience of Médecins Sans Frontières.
- Authors: Pujades-Rodríguez M, O'Brien D, Humblet P, Calmy A
- Issue date: 2008 Jul 11